Startup focused on deep brain stimulation. Joined (pre-revenue, employee #12) as CCO to lead global commercial operations. Also, led product development teams across 4 countries. Promoted to President. Company went public in 2017.

Privately-held startup developer of an implantable neurostimulation therapy for obstructive sleep apnea. Joined pre-revenue, employee #9. Acquired by LivaNova for $225M.As the first member of the commercial operations team, I: built the OUS and US sales and field support team from zero; established sales support infrastructure; initiated KOL development program; developed and delivered the sales training program; created the surgical skills training program; and established marketing infrastructure including marketing communications, product management, and upstream and downstream marketing.

Initiated and led global commercialization of the company's first two deep brain stimulation (DBS) product families consisting of over 20 products in 15 countries, exceeded revenue and profit objectives and completed IDE clinical studies for Parkinson's, essential tremor and depression.

• Promoted to Vice President.

Initiated and led global commercialization of the company's first implantable infusion therapy consisting of over 10 products in 10 countries, and completed an IDE clinical studies for intrathecal morphine for pain.

commercial operations, marketing, sales, logistics,strategy,launch,market entry,medical device commercialization,product management,product manager,brand management,positioning,pricing strategy,market development,strategic marketing,upstream marketing, market research, competitive analysis,customer insights,strategic planning,New business development,partnering,strategic partnership,contract negotiation,strategic alliance,acquisition,M&A,licensing,due diligence,corporate development,technology transfer,tech transfer,trademarks,copyrightsMedical sales,building teams,sales forecasting,sales management,sales training,recruiting,distributor management,distribution network,key opinion leader,KOL development,thought leader,professional education,surgical training,clinical trial,clinical study,clinical research,IDE,pivotal study,clinical strategy,FDA regulatory,reimbursement,evidence developmentLeadership,general management,executive management,cross-functional,C-level,budget,revenue forecasting,profit & loss responsibility,P&L responsibilityMedical device,neuromodulation,active implantable,surgical product,neurosurgery,neurosurgeon, neurology,neurologist,neurophysiology,otorhinolaryngology,ENT,otorhinolaryngologist,head and neck surgeon,pain management,anesthesiology,anesthesiologist,Parkinson,depression,movement disorders,obstructive sleep apnea,OSA,respiratory,pulmonology,pulmonologist,new product development,design controls,biomedical engineeringStart-up,startup,early stage,early-stage,pre-revenue,entrepreneurial,small business,emerging, venture capital,VC funded,private equity,PECEO,President,Chief Operating Officer,COO,Chief Commercialization Officer,CCO,Executive Vice President,EVP,General Manager,GM,Vice President of Marketing,VP Marketing,VP of Marketing,Vice President of Sales & Marketing,VP Sales & Marketing,Vice President Strategy,VP of Strategy,Vice President Strategic Planning,VP of Strategic Planning